1. Home
  2. LNSR vs IXHL Comparison

LNSR vs IXHL Comparison

Compare LNSR & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LENSAR Inc.

LNSR

LENSAR Inc.

HOLD

Current Price

$12.56

Market Cap

136.8M

Sector

Health Care

ML Signal

HOLD

Logo Incannex Healthcare Inc.

IXHL

Incannex Healthcare Inc.

HOLD

Current Price

$0.34

Market Cap

134.7M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
LNSR
IXHL
Founded
2004
2001
Country
United States
Australia
Employees
N/A
N/A
Industry
Medical Electronics
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
136.8M
134.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
LNSR
IXHL
Price
$12.56
$0.34
Analyst Decision
Hold
Analyst Count
1
0
Target Price
$15.00
N/A
AVG Volume (30 Days)
30.5K
6.9M
Earning Date
02-26-2026
02-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$59,141,000.00
$12,000.00
Revenue This Year
$19.55
N/A
Revenue Next Year
$35.89
N/A
P/E Ratio
N/A
N/A
Revenue Growth
21.02
N/A
52 Week Low
$8.25
$0.08
52 Week High
$17.31
$2.25

Technical Indicators

Market Signals
Indicator
LNSR
IXHL
Relative Strength Index (RSI) 68.69 38.59
Support Level $11.86 $0.34
Resistance Level $12.09 $0.37
Average True Range (ATR) 0.31 0.02
MACD 0.06 -0.00
Stochastic Oscillator 99.61 8.24

Price Performance

Historical Comparison
LNSR
IXHL

About LNSR LENSAR Inc.

LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe and Asia.

About IXHL Incannex Healthcare Inc.

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.

Share on Social Networks: